Search Results
QoL for patients with polycythemia vera or essential thrombocythemia
The impact of symptoms on QoL in patients with MPNs
The unmet needs of essential thrombocythemia and polycythemia vera patients
Unmet needs in the polycythemia vera and essential thrombocythemia
Agents of interest being explored in essential thrombocythemia and polycythemia vera
Novel therapeutics in essential thrombocythemia
Essential Thrombocythemia Watch & Wait | What Patients Should Know
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
SURPASS ET: ropeginterferon versus anagrelide as second line therapy in essential thrombocythemia
Case 3: Low- to Intermediate- Risk Essential Thrombocythemia
Case 3: Prediction of Thrombosis in Essential Thrombocythemia
Bomedemstat normalizes platelet count for essential thrombocythemia
